EI
Eikon Therapeutics, Inc. Common Stock (EIKN)
NASDAQ·Healthcare·Biotechnology
$7.98
-11.14%
Mkt Cap $486.17M
Analyst Ratings
Buy
0
Hold
0
Sell
3
Price Target (1 analysts)
$5.00
Range $5.00 – $5.00
Implied Upside
-37.3%
Consensus $5.00 vs current $7.98